EnsoData™, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO) to oversee strategy and execution of sales and marketing functions, grow a world-class team, and continue accelerating adoption across North America.
New position data captured by Night Shift™ adds another physiological channel, including sleep position data, to EnsoSleep PPG
Powered by EnsoSleep PPG, the new RPM offering enables clinicians to both test patients and monitor them longitudinally using a single PPG-based device
“Our partnership with EnsoData allows us to provide an affordable, accessible at-home solution that is paving the way for fast, accurate diagnoses and better health outcomes nationwide,” said Vick Tipnes, Blackstone Medical CEO.
The FDA-cleared Drowzle Pro, rebranded as Celeste+, added three new physical channels to the home sleep apnea testing solution: acoustic flow, snore, and actigraphy which can be displayed in EnsoSleep PPG Study Management.
EnsoData, BodiMetrics announce collaboration to expedite sleep testing, expand long-term patient monitoring. BodiMetrics’ FDA-cleared circul pro™ ring, paired with EnsoSleep PPG advanced AI/ML analysis, offers accessible, comfortable home sleep testing.
Happy Health partnership aims to reduce barriers to care by putting patients in control of their own health journey and enabling nightly monitoring to enhance early stage detection using the Happy Ring and Happy Sleep platform, powered by EnsoData’s EnsoSleep PPG AI algorithm for scoring and analysis of the sleep data.
EnsoData and Nonin partner to offer affordable, non-invasive at home sleep testing for patients at risk of sleep apnea, bringing accessible sleep testing and diagnosis to all audiences, including patients with limited access to care
EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea, allowing EnsoData to improve access and affordability in underserved sleep apnea patient populations.
Partnership Announcement: AI software integration between EnsoData and Parachute Health aims to connect sleep disorder diagnosis to therapy prescription.
Aeroflow and EnsoData usher in a new era in personalized sleep apnea care, population health management, and patient coaching with AI-powered predictive analysis of CPAP monitoring data.
EnsoData announces its FDA-cleared diagnostic AI analysis and sleep scoring solution, EnsoSleep, earned stage-specific autoscoring software certification from the American Academy of Sleep Medicine (AASM).
EnsoData achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
EnsoData and React Health announced a strategic collaboration to optimize PAP adherence support for patients with sleep apnea using EnsoData’s AI technology.
EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s 2023 List of Best Workplaces, marking third consecutive year on the list.
EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide, a milestone reached in May 2023.
EnsoData has appointed Dr. Nathaniel Watson as New Chief Medical Officer, expanding its clinical sleep expertise.
EnsoData’s new funding, coupled with new partnerships and an executive hire, promise rapid growth and accelerated delivery of its validated AI solution for sleep medicine.
EnsoData receives FDA 510(k) clearance of latest sleep center tools to enhance patient care and experience; expands into pediatrics and adds to home testing capabilities.
Cadwell partners with EnsoData with direct integrations to reduce manual data analysis performed by sleep clinicians using Cadwell devices.
By simplifying the process for analyzing the human body to accurately diagnose health conditions, we were thrilled to announce on June 10th the close of our $9 million Series A financing round.
EnsoData, a healthcare artificial intelligence company and maker of FDA-cleared EnsoSleep, publicly announced Tuesday a partnership with LabRetriever [sleep EMR].
EnsoSleep PPG now integrates positional data from Advanced Brain Monitoring’s Night Shift device, enabling the identification of positional obstructive sleep apnea and potentially supporting more personalized CPAP therapy decisions.
A new paper publishes the differences in the costs of Medicare claims for three cohorts: people who met the CPAP adherence threshold, people who started CPAP but did not meet the threshold, and those who did not try CPAP at all.
The FDA-cleared EnsoSleep PPG home sleep test now features position data captured by Advanced Brain Monitoring’s Night Shift sleep positioner.
New PAP Therapy Study Shows Significant Savings Medicare beneficiaries who initiated PAP saved $195 in per-member per-month costs over 24 months.
EnsoData plans to raise the standard of care of sleep and in the future across cardiology, neurology, mental health, and beyond.
EnsoData’s AI-Powered Remote Physiological Monitoring (RPM) solution provides diagnostic-grade AHI data that monitors treatment response longitudinally as patients adjust to sleep apnea therapy.
Sleep Review Summary: EnsoData has launched an RPM solution within its EnsoSleep PPG AI ecosystem, allowing clinicians to continuously track sleep apnea treatment effectiveness via wearable devices with no learning curve.
Partnership Equips Primary Care Physicians with HST Solution
Blackstone Medical, EnsoData partner on home sleep testing
EnsoData’s Celeste+ App Adds 3 Channels to Home Sleep Testing Solution
EnsoData’s Celeste+ App Adds Three New Physical Channels to HSAT
How AI Will Minimize CPAP Failures
Happy Sleep’s sleep ring (Happy Ring) received FDA clearance in October 2024 to monitor health metrics like blood oxygen saturation and pulse rate and, through a partnership with EnsoData, diagnose sleep disorders.
Dr. Watson: It pays to help patients take that final step to initiate successful PAP therapy
As AI changes health care, industry leaders say more work needs to be done
Medicare beneficiaries with common chronic health conditions who complied with PAP therapy saw reduced costs, according to a new study.
Unlocking the Power of Photoplethysmography (PPG) in Sleep Diagnostics
Empowering Dental Practitioners with AI to Expedite the Sleep Apnea Diagnosis to Therapy Pipeline
EnsoData, BodiMetrics Collaborate to Expedite Sleep Testing, Expand Long-Term Monitoring
BodiMetrics and EnsoData Partner to Enhance Home Sleep Apnea Testing
Happy Health Partners with EnsoData to Simplify OSA At-Home Diagnosis and RPM
Happy Ring Maker and EnsoData Offer Home Sleep Testing Solution
What’s ‘next chapter’ in HME data?
EnsoData, Happy Health partner on sleep monitoring
How Software Can Simplify Hypopnea Scoring for Varied Payors
The below gallery includes photos for use by members of the media. For press inquiries or to reach out to our EnsoData team to schedule an interview, podcast guest, or with any other general inquiries at team@ensodata.com.
Andrea Ramberg, RPSGT, CCSH EnsoData Clinical Director
Learn More about EnsoSleep and Get Our Resources Delivered Straight to Your Inbox
